Special Sections: Letters to the Editor

Lenalidomide Therapy in a Rare Case of POEMS Syndrome with Kappa Restriction

Authors: Saurabh Sethi MD, Nishant Tageja MD, Haitham Arabi MD, Raju Penumetcha MD

Abstract

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

References1. Dispenzieri A. POEMS syndrome. Blood Rev 2007;21:285–299.DispenzieriAPOEMS syndrome.Blood Rev200721285-2992. Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome. Blood 2003;101:2496–2506.DispenzieriA]]KyleRA]]LacyMQ&etal;POEMS syndrome: definitions and long-term outcome.Blood20031012496-25063. Badros A, Porter N, Zimrin A. Bevacizumab therapy for POEMS syndrome. Blood 2005;106:1135.BadrosA]]PorterN]]ZimrinABevacizumab therapy for POEMS syndrome.Blood200510611354. Dispenzieri A, Klein CJ, Mauermann ML. Lenalidomide therapy in a patient with POEMS syndrome. Blood 2007;110:1075–1076.DispenzieriA]]KleinCJ]]MauermannMLLenalidomide therapy in a patient with POEMS syndrome.Blood20071101075-1076